1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. タイプ別スニペット
3.2. 製品別スニペット
3.3. ソース別スニペット
3.4. 販売チャネル別スニペット
3.5. 用途別スニペット
3.6. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 慢性疾患の増加
4.1.1.2. 革新的な薬事承認と製剤の強化
4.1.2. 阻害要因
4.1.2.1. 多様な規制枠組み
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. DMI意見
6. タイプ別
6.1. はじめに
6.1.1. 市場規模分析および前年比成長率分析（%）, タイプ別
6.1.2. 市場魅力度指数（タイプ別
6.2. ハーブ
6.2.1. はじめに
6.2.2. 市場規模分析と前年比成長率分析(%)
6.3. タンパク質・ペプチド
6.4. ビタミン・ミネラル
6.5. プレバイオティクスとプロバイオティクス
6.6. その他（脂肪酸と食物繊維）
7. 製品別
7.1. 製品紹介
7.2. 市場規模分析および前年比成長率分析（%）, 製品別
7.3. 市場魅力度指数, 製品別
7.4. 機能性食品
7.4.1. はじめに
7.4.2. 市場規模分析と前年比成長率分析(%)
7.4.3. シリアル
7.4.4. ベーカリー・菓子
7.4.5. 乳製品
7.4.6. スナック
7.4.7. その他
7.5. 機能性飲料
7.5.1. エネルギー飲料
7.5.2. 乳製品・乳製品代替飲料
7.5.3. 果物・野菜ジュース・飲料
7.5.4. 非炭酸飲料
7.5.5. その他
7.6. 栄養補助食品
7.6.1. 錠剤
7.6.2. 液体
7.6.3. 粉末
7.6.4. その他
7.7. パーソナルケア
8. ソース別
8.1. はじめに
8.2. 供給源別市場規模分析および前年比成長率分析(%)
8.3. 市場魅力度指数, 供給源別
8.4. 植物ベース
8.4.1. はじめに
8.4.2. 市場規模分析と前年比成長率分析(%)
8.5. 動物ベース
8.6. 微生物ベース
9. 流通チャネル別
9.1. はじめに
9.2. 市場規模分析および前年比成長率分析（%）, 流通チャネル別
9.3. 市場魅力度指数（流通チャネル別
9.4. スーパーマーケット／ハイパーマーケット
9.4.1. はじめに
9.4.2. 市場規模分析と前年比成長率分析(%)
9.5. コンビニエンスストア
9.6. 専門店
9.7. ドラッグストア／薬局
9.8. オンライン小売店
9.9. その他
10. 用途別
10.1. はじめに
10.2. 市場規模分析および前年比成長率分析（%）, アプリケーション別
10.3. 市場魅力度指数（用途別
10.4. ヘルス＆ウェルネス
10.4.1. はじめに
10.4.2. 市場規模分析と前年比成長率分析(%)
10.5. スポーツ栄養
10.6. 臨床栄養
11. 地域別
11.1. はじめに
11.1.1. 地域別市場規模分析および前年比成長率分析(%)
11.1.2. 市場魅力度指数、地域別
11.2. 北米
11.2.1. 序論
11.2.2. 主な地域別ダイナミクス
11.2.3. 市場規模分析および前年比成長率分析（%）, タイプ別
11.2.4. 市場規模分析とYoY成長率分析(%)、製品別
11.2.5. 市場規模分析および前年比成長率分析 (%)、ソース別
11.2.6. 市場規模分析および前年比成長率分析（%）, 流通チャネル別
11.2.7. 市場規模分析および前年比成長率分析（%）, アプリケーション別
11.2.8. 市場規模分析および前年比成長率分析（%）, 国別
11.2.8.1. 米国
11.2.8.2. カナダ
11.2.8.3. メキシコ
11.3. ヨーロッパ
11.3.1. はじめに
11.3.2. 主な地域別動向
11.3.3. 市場規模分析および前年比成長率分析（%）, タイプ別
11.3.4. 市場規模分析とYoY成長率分析(%)、製品別
11.3.5. 市場規模分析および前年比成長率分析(%)、ソース別
11.3.6. 市場規模分析および前年比成長率分析（%）, 流通チャネル別
11.3.7. 市場規模分析および前年比成長率分析 (%)、用途別
11.3.8. 市場規模分析および前年比成長率分析（%）, 国別
11.3.8.1. ドイツ
11.3.8.2. イギリス
11.3.8.3. フランス
11.3.8.4. イタリア
11.3.8.5. スペイン
11.3.8.6. その他のヨーロッパ
11.4. 南米
11.4.1. はじめに
11.4.2. 地域別主要市場
11.4.3. 市場規模分析および前年比成長率分析（%）, タイプ別
11.4.4. 市場規模分析および前年比成長率分析 (%)、製品別
11.4.5. 市場規模分析および前年比成長率分析 (%)、ソース別
11.4.6. 市場規模分析および前年比成長率分析（%）, 流通チャネル別
11.4.7. 市場規模分析および前年比成長率分析 (%)、用途別
11.4.8. 市場規模分析および前年比成長率分析（%）, 国別
11.4.8.1. ブラジル
11.4.8.2. アルゼンチン
11.4.8.3. その他の南米諸国
11.5. アジア太平洋
11.5.1. はじめに
11.5.2. 主な地域別ダイナミクス
11.5.3. 市場規模分析および前年比成長率分析（%）, タイプ別
11.5.4. 市場規模分析とYoY成長率分析(%)、製品別
11.5.5. 市場規模分析および前年比成長率分析 (%)、ソース別
11.5.6. 市場規模分析および前年比成長率分析（%）, 流通チャネル別
11.5.7. 市場規模分析および前年比成長率分析（%）, アプリケーション別
11.5.8. 市場規模分析および前年比成長率分析（%）, 国別
11.5.8.1. 中国
11.5.8.2. インド
11.5.8.3. 日本
11.5.8.4. オーストラリア
11.5.8.5. その他のアジア太平洋地域
11.6. 中東・アフリカ
11.6.1. 序論
11.6.2. 主な地域別ダイナミクス
11.6.3. 市場規模分析および前年比成長率分析（%）, タイプ別
11.6.4. 市場規模分析とYoY成長率分析(%)、製品別
11.6.5. 市場規模分析および前年比成長率分析 (%)、ソース別
11.6.6. 市場規模分析および前年比成長率分析 (%)、流通チャネル別
11.6.7. 市場規模分析および前年比成長率分析（%）, アプリケーション別
12. 競合情勢
12.1. 競争シナリオ
12.2. 市場ポジショニング／シェア分析
12.3. M&A分析
13. 企業プロフィール
13.1. Danone S.A.
13.1.1. 会社概要
13.1.2. 製品ポートフォリオと説明
13.1.3. 財務概要
13.1.4. 主な展開
13.2. Glanbia plc
13.3. Nestle S.A.
13.4. Bayer AG
13.5. Abbott Nutrition
13.6. GNC Holdings, LLC
13.7. Garden of Life
13.8. NOW Foods
13.9. Kellanova
13.10. Parry Nutraceuticals Limited（※リストは除く）
14. 付録
14.1. 当社とサービスについて
14.2. お問い合わせ
Global Nutraceuticals Market reached US$ 443.1 billion in 2023 and is expected to reach US$ 684.2 billion by 2031, growing with a CAGR of 5.58% during the forecast period 2024-2031.
Increasing consumer awareness about the benefits of a healthy lifestyle has led to greater demand for health supplements, particularly among aging populations who prioritize wellness. The rising incidence of lifestyle-related chronic diseases has also emphasized the need for preventive care through dietary choices. Additionally, the growth of e-commerce has made nutraceuticals more accessible to consumers, facilitating their purchase.
The market is poised for further expansion, with trends such as personalized nutrition based on individual genetic and lifestyle factors, a heightened focus on sustainability and ongoing innovation in product development. For instance, in July 2024, Renewtra has launched as a new brand in India’s nutraceutical industry, aiming to revolutionize the market with its clinically proven, transparent-label products.
High rates of diabetes and obesity in US drive North America's dominance in the global nutraceuticals market. With approximately 37.3 million Americans having diabetes and over 41.9% of adults classified as obese, there is a growing demand for supplements and functional foods. As health-conscious consumers seek effective solutions, North America remains a leader in the nutraceutical industry.
Market Dynamics
Rise of Chronic Diseases
The frightening rise in obesity, diabetes and cardiovascular diseases (CVDs) is significantly driving the global nutraceutical market. With over 1 billion people affected by obesity and 537 million adults living with diabetes, the urgency for effective management solutions has never been clearer. Consumers are increasingly seeking nutraceutical products derived from food sources with health benefits that can help prevent or manage these chronic conditions.
The shift towards preventive health measures reflects a growing awareness of the critical link between diet and disease, prompting individuals to explore natural options that enhance well-being. Moreover, the rising health consciousness among consumers, fueled by concerns over chronic disease prevalence, is propelling the nutraceutical market forward.
Innovative Regulatory Approvals And Enhanced Formulations
The global nutraceutical market is driven by innovative regulatory approvals and enhanced formulations. In November 2022, Geno's launch of Avela natural (R)-1,3-Butanediol provides a sugar-free ingredient that elevates beta-hydroxybutyrate levels, enhancing mental clarity and athletic performance without requiring restrictive diets. Derived from plant sugars through sustainable fermentation, Avela aligns with the increasing consumer demand for natural products.
Additionally, regulatory approvals, such as the European Commission’s endorsement of Carbopol Polymers, in October 2023, enable the creation of innovative, easier-to-swallow formulations. Together, these advancements cater to diverse consumer needs and preferences, driving the evolution of functional foods and positioning the nutraceutical market for sustained growth.
Diverse Regulatory Frameworks
The global nutraceuticals market faces significant
Restraints due to diverse regulatory frameworks. Each country has its classification criteria, considering different product perceptions from one region to another. This inconsistency complicates compliance, forcing companies to allocate time and resources to navigate various regulations. Additionally, strict marketing guidelines in some areas limit the health claims that can be made, hindering companies' ability to attract consumers.
Market Segment Analysis
The global nutraceuticals market is segmented based on type, product, source, distribution channel, application and region.
Superior Performance and Yield Potential of Hybrid Seeds
The plant-based segment dominates the global nutraceuticals market based on source. This is primarily due to the increasing consumer demand for natural and organic products, as well as growing awareness of the health benefits associated with plant-derived ingredients. Additionally, trends toward vegetarian and vegan diets contribute to the popularity of plant-based nutraceuticals.
The increasing number of vegans, estimated at around 88 million in 2022, significantly impacts the popularity of plant-based nutraceuticals. As more people adopt vegetarian and vegan diets, there’s a growing demand for products that meet their nutritional needs without animal-derived ingredients. This trend is driving innovation and expansion in the plant-based sector, driving segment growth.
Market Geographical Share
Rising Health Consciousness Among North American Population
North America dominates the global nutraceuticals market. A high level of consumer awareness regarding wellness strongly supports North America's leadership in the worldwide market. The 2023 CRN Consumer Survey on Dietary Supplements reveals that 74% of US adults take dietary supplements, with 55% classified as regular users. This significant adoption enhances the vital role that supplements play in the daily health routines of Americans.
The widespread usage reflects a robust commitment to preventive health measures and a growing recognition of the benefits of nutraceuticals, driver market dominance, bolstered by effective education initiatives, a diverse range of product offerings health and a supportive regulatory environment. As reliance on dietary supplements continues to rise, it aligns with the broader movement towards holistic health, further solidifying their essential place in everyday life.
Market Competitive Landscape
The major global players in the market include Danone S.A., Glanbia plc, Nestle S.A., Bayer AG, Abbott Nutrition, GNC Holdings, LLC, Garden of Life, NOW Foods, Kellanova and Parry Nutraceuticals Limited.
Russia-Ukraine War Impact
The Russia-Ukraine war has impacted the global nutraceuticals market by disrupting supply chains and causing fluctuations in raw material prices. Shortages of key agricultural products have increased costs and affected availability. Additionally, geopolitical tensions have led companies to rethink sourcing strategies, while rising consumer interest in health and wellness has driven demand for nutraceuticals.
By Type
Herbals
Proteins & Peptides
Vitamins & Minerals
Prebiotics and Probiotics
Others (Fatty Acids and Fiber)
By Product
Functional Food
Cereal
Bakery and Confectionary
Dairy
Snack
Other
Functional Beverages
Energy Drinks
Dairy & Dairy Alternative Drinks
Fruit & Vegetable Juices and Drinks
Noncarbonated Drinks
Other
Dietary Supplements
Tablets
Liquid
Powder
Others
Personal Care
By Source
Plant-Based
Animal-Based
Microbial
By Distribution Channel
Supermarkets/Hypermarkets
Convenience Stores
Specialty Stores
Drug Stores/Pharmacies
Online Retail Stores
Other
By Application
Health and Wellness
Sports Nutrition
Clinical Nutrition
By Region
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Middle East and Africa
Key Developments
In September 2024, Floré launched a probiotic line for neurodiversity, including pathways support and mood support, formulated for individuals with autism spectrum disorder (ASD). Developed in collaboration with Arizona State University, these products were based on a clinical study that showed significant improvements in gastrointestinal discomfort and cognitive abilities among ASD participants after three months of treatment.
In June 2024, Steadfast Nutrition launched three new supplements: Whey Protein, LIV Raw and a vegetarian Multivitamin mega pack with 180 tablets. These products cater to the protein and nutrient needs of health-conscious individuals and athletes. The launch took place at the International Health Sports and Fitness Festival (IHFF), Asia’s largest health and fitness event.
In June 2024, RSSL introduced a new dietary supplement testing service to support clients in R&D, manufacturing and supply chain functions. This service ensures reliable turnaround and quality results, offering analyses such as nutrition testing, novel ingredient evaluation and regulatory support to meet clients' needs efficiently.
Why Purchase the Report?
To visualize the global nutraceuticals market segmentation based on type, product, source, distribution channel, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel spreadsheet containing a comprehensive dataset of the Nutraceuticals market, covering all levels of segmentation.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.
The global nutraceuticals market report would provide approximately 78 tables, 79 figures and 224 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Product
3.3. Snippet by Source
3.4. Snippet by Distribution Channel
3.5. Snippet by Application
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise of Chronic Diseases
4.1.1.2. Innovative Regulatory Approvals and Enhanced Formulations
4.1.2. Restraints
4.1.2.1. Diverse Regulatory Frameworks
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. By Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Herbals
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Proteins & Peptides
6.4. Vitamins & Minerals
6.5. Prebiotics and Probiotics
6.6. Others (Fatty Acids and Fiber)
7. By Product
7.1. Introduction
7.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.3. Market Attractiveness Index, By Product
7.4. Functional Food
7.4.1. Introduction
7.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.4.3. Cereal
7.4.4. Bakery and Confectionary
7.4.5. Dairy
7.4.6. Snack
7.4.7. Other
7.5. Functional Beverages
7.5.1. Energy Drinks
7.5.2. Dairy & Dairy Alternative Drinks
7.5.3. Fruit & Vegetable Juices and Drinks
7.5.4. Noncarbonated Drinks
7.5.5. Other
7.6. Dietary Supplements
7.6.1. Tablets
7.6.2. Liquid
7.6.3. Powder
7.6.4. Others
7.7. Personal Care
8. By Source
8.1. Introduction
8.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
8.3. Market Attractiveness Index, By Source
8.4. Plant-Based
8.4.1. Introduction
8.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.5. Animal-Based
8.6. Microbial
9. By Distribution Channel
9.1. Introduction
9.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.3. Market Attractiveness Index, By Distribution Channel
9.4. Supermarkets/Hypermarkets
9.4.1. Introduction
9.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.5. Convenience Stores
9.6. Specialty Stores
9.7. Drug Stores/Pharmacies
9.8. Online Retail Stores
9.9. Other
10. By Application
10.1. Introduction
10.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3. Market Attractiveness Index, By Application
10.4. Health and Wellness
10.4.1. Introduction
10.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.5. Sports Nutrition
10.6. Clinical Nutrition
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.8.1. US
11.2.8.2. Canada
11.2.8.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.8.1. Germany
11.3.8.2. UK
11.3.8.3. France
11.3.8.4. Italy
11.3.8.5. Spain
11.3.8.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.8.1. Brazil
11.4.8.2. Argentina
11.4.8.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.8.1. China
11.5.8.2. India
11.5.8.3. Japan
11.5.8.4. Australia
11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Danone S.A.
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Glanbia plc
13.3. Nestle S.A.
13.4. Bayer AG
13.5. Abbott Nutrition
13.6. GNC Holdings, LLC
13.7. Garden of Life
13.8. NOW Foods
13.9. Kellanova
13.10. Parry Nutraceuticals Limited (*LIST NOT EXHAUSTIVE)
14. Appendix
14.1. About Us and Services
14.2. Contact Us
❖ 世界の栄養補助食品市場に関するよくある質問(FAQ) ❖
・栄養補助食品の世界市場規模は？
→DataM Intelligence社は2023年の栄養補助食品の世界市場規模を4,431億米ドルと推定しています。
・栄養補助食品の世界市場予測は？
→DataM Intelligence社は2031年の栄養補助食品の世界市場規模を6,842億米ドルと予測しています。
・栄養補助食品市場の成長率は？
→DataM Intelligence社は栄養補助食品の世界市場が2024年～2031年に年平均5.6%成長すると予測しています。
・世界の栄養補助食品市場における主要企業は？
→DataM Intelligence社は「Danone S.A.、Glanbia plc、Nestle S.A.、Bayer AG、Abbott Nutrition、GNC Holdings, LLC、Garden of Life、NOW Foods、Kellanova、Parry Nutraceuticals Limitedなど ...」をグローバル栄養補助食品市場の主要企業として認識しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、納品レポートの情報と少し異なる場合があります。
